Provided by Tiger Trade Technology Pte. Ltd.

Korsana Biosciences Inc

37.56
+2.115.95%
Post-market: 37.560.00000.00%19:30 EST
Volume:265.24K
Turnover:9.90M
Market Cap:1.71B
PE:-2.81
High:39.41
Open:35.63
Low:34.08
Close:35.45
52wk High:59.36
52wk Low:7.19
Shares:45.50M
Float Shares:45.04M
Volume Ratio:1.01
T/O Rate:0.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.3710
EPS(LYR):-12.2039
ROE:--
ROA:--
PB:-36.34
PE(LYR):-3.08

Loading ...

Korsana Biosciences Holds Special Shareholder Meeting

Reuters
·
Nov 20

Korsana Biosciences, Inc. : Wells Fargo Initiates Coverage with Overweight Rating and Target Price $44

THOMSON REUTERS
·
Nov 13

Korsana Biosciences Q3 EPS $(3.19) Misses $(0.85) Estimate

Benzinga Earnings
·
Nov 05

Korsana Biosciences Names Heidi Henson Director and Audit Committee Chair

Reuters
·
Nov 05

Korsana Biosciences, Inc.: Qtrly Net Loss Per Share $3.19

THOMSON REUTERS
·
Nov 05

Korsana Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Nov 05

Korsana Biosciences Announces Participation in Four Investor Conferences

Reuters
·
Nov 03

Korsana Biosciences initiated with a Buy at Guggenheim on KRSA-028 potential

TIPRANKS
·
Oct 06

Korsana Biosciences, Inc. : Wedbush Initiates Coverage with Outperform Rating; Target Price $44

THOMSON REUTERS
·
Oct 05

Guggenheim Initiates Korsana Biosciences at Buy With $70 Price Target

MT Newswires Live
·
Sep 28

Korsana Biosciences Initiated at Buy by TD Cowen

Dow Jones
·
Sep 14

U.S. Research Roundup-ACV Auctions, Crown Castle, Lennox International

Reuters
·
Sep 14

Stifel Initiates Korsana Biosciences at Buy With $43 Price Target

MT Newswires Live
·
Sep 14

Korsana Biosciences initiated with a Buy at TD Cowen

TIPRANKS
·
Sep 14

Korsana Biosciences, Inc. : TD Cowen Initiates Coverage with Buy Rating

THOMSON REUTERS
·
Sep 14

Korsana Biosciences Completes Merger with Cyclerion Therapeutics, to Trade as KRSA on NASDAQ

Reuters
·
Sep 12

Korsana Biosciences, Inc. : UBS Initiates Coverage with Buy Rating and Target Price $55

THOMSON REUTERS
·
Sep 11

Korsana Biosciences Price Target Announced at $55.00/Share by UBS

Dow Jones
·
Sep 11

Korsana Biosciences initiated with a Buy at UBS

TIPRANKS
·
Sep 11

Cyclerion Therapeutics trading halted, news pending

TIPRANKS
·
Sep 09